• OPEN AN ACCOUNT
Indian Indices
Sensex
73,400.70 276.87
( 0.38%)
Global Indices
Nasdaq
52,230.09 -658.89
(-1.25%)
Dow Jones
7,644.13 -40.30
(-0.52%)
Hang Seng
62,433.43 -259.73
(-0.41%)
Nikkei 225
10,670.63 -54.40
(-0.51%)
Forex
USD-INR
94.61 0.10
(0.11%)
EUR-INR
106.18 0.08
(0.07%)
GBP-INR
126.70 0.19
(0.15%)
JPY-INR
0.60 0.00
(0.70%)

EQUITY - MARKET SCREENER

Novartis India Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500672
INE234A01025
331.2308625
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NOVARTIND
46.33
4530.14
EPS(TTM)
Face Value()
Div & Yield %
39.6
5
1.36
 

oxygenta pharmaceutical ltd
All E Technologies consolidated net profit declines 19.94% in the June 2026 quarter
Aug 15,2026
Net profit of All E Technologies declined 19.94% to Rs 5.06 crore in the quarter ended June 2026 as against Rs 6.32 crore during the previous quarter ended June 2025. Sales rose 9.13% to Rs 37.18 crore in the quarter ended June 2026 as against Rs 34.07 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales37.1834.07 9
OPM %12.5119.17 -
PBDT6.978.78 -21
PBT6.648.48 -22
NP5.066.32 -20